|
Volumn 40, Issue 22, 1997, Pages 3504-3507
|
Bicyclo[2.2.1]heptane and 6,6-dimethylbicyclo[3.1.1]heptane derivatives: Orally active, potent, and selective prostaglandin D2 receptor antagonists
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID;
6,6 DIMETHYLBICYCLO[3.1.1]HEPTANE DERIVATIVE;
7 [3 [(BIPHENYL 4 YLSULFONYL)AMINO]BICYCLO[2.2.1]HEPT 2 YL]HEPT 5 ENOIC ACID;
NORBORNANE DERIVATIVE;
PROSTAGLANDIN D2;
PROSTAGLANDIN RECEPTOR BLOCKING AGENT;
THROMBOXANE SYNTHASE INHIBITOR;
UNCLASSIFIED DRUG;
ALLERGY;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
ASTHMA;
BRONCHODILATATION;
CONJUNCTIVITIS;
DRUG BIOAVAILABILITY;
DRUG CONFORMATION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
ENANTIOMER;
GUINEA PIG;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
ADMINISTRATION, ORAL;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BICYCLO COMPOUNDS;
BLOOD PLATELETS;
GUINEA PIGS;
HUMANS;
NORBORNANES;
PROSTAGLANDIN D2;
RECEPTORS, IMMUNOLOGIC;
RECEPTORS, PROSTAGLANDIN;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0030668052
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm970343g Document Type: Article |
Times cited : (36)
|
References (18)
|